BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 44 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $4,380,248 | -35.1% | 4,448,000 | -32.2% | 0.06% | -22.7% |
Q1 2023 | $6,747,850 | +157.5% | 6,561,000 | +166.4% | 0.08% | +167.9% |
Q4 2022 | $2,620,139 | +55.2% | 2,463,000 | +44.9% | 0.03% | +47.4% |
Q3 2022 | $1,688,000 | +0.1% | 1,700,000 | 0.0% | 0.02% | -5.0% |
Q2 2022 | $1,687,000 | -51.9% | 1,700,000 | -51.4% | 0.02% | -45.9% |
Q1 2022 | $3,507,000 | -18.4% | 3,500,000 | -14.7% | 0.04% | -21.3% |
Q4 2021 | $4,300,000 | -0.1% | 4,103,000 | -2.3% | 0.05% | -21.7% |
Q3 2021 | $4,305,000 | -51.2% | 4,198,000 | -50.6% | 0.06% | -49.6% |
Q2 2021 | $8,829,000 | +1690.9% | 8,500,000 | +1708.5% | 0.12% | +750.0% |
Q1 2020 | $493,000 | -86.7% | 470,000 | -86.6% | 0.01% | -80.0% |
Q4 2019 | $3,706,000 | +72.1% | 3,500,000 | +66.7% | 0.07% | +70.7% |
Q1 2019 | $2,154,000 | -85.4% | 2,100,000 | -85.8% | 0.04% | -69.4% |
Q4 2018 | $14,754,000 | -26.8% | 14,800,000 | -21.5% | 0.13% | -50.6% |
Q3 2018 | $20,150,000 | -34.8% | 18,865,000 | -38.1% | 0.27% | -37.3% |
Q2 2018 | $30,887,000 | +512.6% | 30,500,000 | +515.8% | 0.43% | +476.0% |
Q3 2017 | $5,042,000 | – | 4,953,000 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Wellesley Asset Management | 53,670 | $57,726,000 | 3.34% |
SHENKMAN CAPITAL MANAGEMENT INC | 26,959,000 | $29,149,000 | 3.04% |
ADVENT CAPITAL MANAGEMENT /DE/ | 84,134,000 | $90,539,000 | 1.93% |
Cheyne Capital Management (UK) LLP | 3,220,000 | $3,452,000 | 1.75% |
PFM Health Sciences, LP | 40,300,000 | $43,210,000 | 1.52% |
Sonora Investment Management, LLC | 6,370,000 | $6,807,000 | 0.56% |
MACKAY SHIELDS LLC | 66,018,000 | $70,980,000 | 0.49% |
ZAZOVE ASSOCIATES LLC | 1,500,000 | $1,608,000 | 0.20% |
IRON Financial LLC | 275,000 | $295,000 | 0.15% |
PALISADE CAPITAL MANAGEMENT, LP | 3,000,000 | $3,216,000 | 0.08% |